Controlled Substances Updates

Campus researchers who are using the drug Xylazine in their research protocols should be aware that xylazine is increasingly being used as illicitly, and recent communication from Boulder County Public Health indicates that it is present in the local illicit drug supply. In order to prevent improper use of xylazine,...

Effective May 11th, 2022, the DEA will require all applications for DEA registrations, and renewal of those registrations, to be submitted online. For more information, please see the official notice in the Federal Register . If you have questions about this update, please reach out to Tom Heddleston at the...

As of January 2022, all Key Participants identified in an CDA hemp application need to complete criminal history background checks. For Universities, the lead researcher for the research project has been identified as a Key Participant. If you plan on conducting hemp research at CU Boulder, please see here for...

To help researchers stay in compliance with the new USDA Final Rule, CU Boulder recently updated the form process for conducting research that involves hemp or hemp-derived products.

The DEA recently announced that effective 10/31/2021, it is shifting its DEA Form 222 from a triplicate-paper to a single sheet for controlled substance schedules 1, 2 and 2N.